FDA Adverse Event Injury Summary report: N

WALLFLEX BILIARY RX PARTIALLY-COVERED STENT SYSTEM

MDR report key: 2143186 · Received June 28, 2011

Report

Report Number
3005099803-2011-02295
Event Type
Injury
Date Received
June 28, 2011
Date of Event
May 18, 2011
Report Date
June 9, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
FGE
PMA / PMN Number
K083374
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE COMPLAINANT INDICATED THAT THE DEVICE WAS IMPLANTED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE CANNOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A WALLFLEX BILIARY RX PARTIALLY COVERED STENT WAS IMPLANTED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE ON (B)(6), 2010. ACCORDING TO THE COMPLAINANT, THE PATIENT HAD A STRICTURE WITHIN THE DISTAL COMMON BILE DUCT DUE TO A MALIGNANCY. THE STRICTURE WAS APPROXIMATELY 2CM IN LENGTH. THE STENT WAS PLACED SUCCESSFULLY ON (B)(6), 2010 WITH NO COMPLICATIONS. ON (B)(6), 2011, THE PATIENT DEVELOPED JAUNDICE AND CHOLANGITIS. THE PATIENT HAD A BILIRUBIN LEVEL OF "386" AND A C-REACTIVE PROTEIN (CRP) LEVEL OF "36." THE STENT WAS FOUND TO BE OBSTRUCTED LIKELY DUE TO TUMOR INGROWTH. THE PATIENT UNDERWENT A SECOND ERCP PROCEDURE. DURING THIS PROCEDURE, A SECOND STENT WAS IMPLANTED WITHIN THE EXISTING WALLFLEX STENT. FOLLOWING THE PLACEMENT OF THE SECOND STENT, THE PATIENT'S SYMPTOMS RESOLVED AND NO FURTHER MEDICAL INTERVENTION WAS REQUIRED. THE PATIENT CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE "STABLE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 WALLFLEX BILIARY RX PARTIALLY-COVERED STENT SYSTEM CATHETER, BILIARY, DIAGNOSTIC FGE BOSTON SCIENTIFIC - GALWAY M00570740 0012233610

Patients

Seq Age Sex Outcome Treatment
1 88 YR Required Intervention